PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 234 filers reported holding PDL BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $8,893,000 | -0.2% | 2,670,761 | +7.2% | 0.02% | 0.0% |
Q4 2015 | $8,908,000 | -29.5% | 2,491,781 | -0.8% | 0.02% | -33.3% |
Q3 2015 | $12,633,000 | +37.6% | 2,511,507 | +75.9% | 0.02% | +60.0% |
Q2 2015 | $9,181,000 | -31.0% | 1,427,935 | -24.5% | 0.02% | -37.5% |
Q1 2015 | $13,298,000 | -1.8% | 1,890,287 | +7.7% | 0.02% | 0.0% |
Q4 2014 | $13,535,000 | -6.4% | 1,755,580 | -9.3% | 0.02% | -7.7% |
Q3 2014 | $14,461,000 | -30.3% | 1,936,010 | -9.7% | 0.03% | -27.8% |
Q2 2014 | $20,751,000 | +18.6% | 2,143,851 | +1.8% | 0.04% | +16.1% |
Q1 2014 | $17,498,000 | -6.2% | 2,105,449 | +2.6% | 0.03% | -8.8% |
Q4 2013 | $18,652,000 | +10.0% | 2,053,039 | -3.5% | 0.03% | +13.3% |
Q3 2013 | $16,952,000 | +5.1% | 2,126,954 | +1.8% | 0.03% | 0.0% |
Q2 2013 | $16,128,000 | – | 2,089,055 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
Leap Investments LP | 69,496 | $150,000 | 0.08% |
Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |